A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy

Xenon 304

This trial is Currently recruiting
Registration number NCT05718817
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy

Program & service

This trial is being run with the Brain service, and as part of the Epilepsy program.

Trial phase

Phase 3

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principal investigator

Dr Richard Chang

Key inclusion data

Must have completed previous double blind portion of the parent study (XPF010-301 or XPF-010-303); Patient must consent to the new protocol; Patient must continue to adhere to study protocol, seizure diary and contraception requirements.

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.